467 related articles for article (PubMed ID: 35127797)
1. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease.
Guo X; Huang C; Xu J; Xu H; Liu L; Zhao H; Wang J; Huang W; Peng W; Chen Y; Nie Y; Zhou Y; Zhou Y
Front Nutr; 2021; 8():818902. PubMed ID: 35127797
[TBL] [Abstract][Full Text] [Related]
2. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction.
Zhou Y; Xu ZZ; He Y; Yang Y; Liu L; Lin Q; Nie Y; Li M; Zhi F; Liu S; Amir A; González A; Tripathi A; Chen M; Wu GD; Knight R; Zhou H; Chen Y
mSystems; 2018; 3(1):. PubMed ID: 29404425
[TBL] [Abstract][Full Text] [Related]
4. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.
Klingberg E; Magnusson MK; Strid H; Deminger A; Ståhl A; Sundin J; Simrén M; Carlsten H; Öhman L; Forsblad-d'Elia H
Arthritis Res Ther; 2019 Nov; 21(1):248. PubMed ID: 31771630
[TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Gut Microbiota as Early Biomarkers for Predicting Inflammatory Bowel Disease Onset and Progression: A Systematic Review.
Boppana K; Almansouri NE; Bakkannavar S; Faheem Y; Jaiswal A; Shergill K; Nath TS
Cureus; 2024 Apr; 16(4):e58080. PubMed ID: 38741828
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
8. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).
Vatn S; Carstens A; Kristoffersen AB; Bergemalm D; Casén C; Moen AEF; Tannaes TM; Lindstrøm J; Detlie TE; Olbjørn C; Lindquist CM; Söderholm JD; Gomollón F; Kalla R; Satsangi J; Vatn MH; Jahnsen J; Halfvarson J; Ricanek P;
Scand J Gastroenterol; 2020 Oct; 55(10):1146-1156. PubMed ID: 32780604
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
10. Microbial Disruptions in Inflammatory Bowel Disease: A Comparative Analysis.
Ma J; Wang K; Wang J; Zeng Q; Liu K; Zheng S; Chen Y; Yao J
Int J Gen Med; 2024; 17():1355-1367. PubMed ID: 38601196
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
Coufal S; Galanova N; Bajer L; Gajdarova Z; Schierova D; Jiraskova Zakostelska Z; Kostovcikova K; Jackova Z; Stehlikova Z; Drastich P; Tlaskalova-Hogenova H; Kverka M
Cells; 2019 Jul; 8(7):. PubMed ID: 31337064
[TBL] [Abstract][Full Text] [Related]
12. Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients.
Santoru ML; Piras C; Murgia A; Palmas V; Camboni T; Liggi S; Ibba I; Lai MA; Orrù S; Blois S; Loizedda AL; Griffin JL; Usai P; Caboni P; Atzori L; Manzin A
Sci Rep; 2017 Aug; 7(1):9523. PubMed ID: 28842640
[TBL] [Abstract][Full Text] [Related]
13. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels.
Alam MT; Amos GCA; Murphy ARJ; Murch S; Wellington EMH; Arasaradnam RP
Gut Pathog; 2020; 12():1. PubMed ID: 31911822
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H; Jain D; Tang DWT; Wong SH; Lal D
Intest Res; 2024 Jan; 22(1):15-43. PubMed ID: 37935653
[TBL] [Abstract][Full Text] [Related]
16. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease.
Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609
[TBL] [Abstract][Full Text] [Related]
17. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
19. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
20. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
